Journal of Andrology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Published-Ahead-of-Print July 12, 2006, DOI:10.2164/jandrol.106.000034

This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
27/6/780    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caroppo, E.
Right arrow Articles by D'Amato, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caroppo, E.
Right arrow Articles by D'Amato, G.

Detection of 90K/MAC-2BP in the seminal plasma of infertile males with accessory gland infection and the autoimmune pathogenetic hypothesis

Ettore Caroppo *, Craig Neiderberger , Palma A Iacovazzi , Mario Correale , and Giuseppe D'Amato

* To whom correspondence should be addressed. E-mail: ecaroppo{at}teseo.it.

Purpose: to evaluate 90K/MAC-2BP, a glycoprotein member of the Scavenger Receptor Cystein Rich superfamily, in the seminal plasma of infertile male patients with male accessory gland infection in order to investigate a putative autoimmune pathogenesis. Materials and Methods: 90K seminal concentration and sperm parameters were evaluated in 50 patients with male accessory gland infection at baseline and after cycles of treatment with Levofluoxacin 500 mg daily for 15 days plus serratiopeptidase 10 mg daily for 30 days. Treatment was continued for up to 6 cycles in cases of persistant bacteriospermia and/or clinical and ejaculatory signs of the disease. Patients with persistant male accessory gland infection after 6 cycles were defined as non-responders. The same parameters were evaluated at baseline and after a two month period in 30 healthy controls. Results: Patients with male accessory gland infection showed impaired sperm parameters and had lower seminal 90K concentration compared to controls. After treatment, seminal 90K significantly increased in patients compared to controls. 22 patients responded to treatment (44%), while 28 were non-responders (56%). No difference in pre-treatment and post-treatment sperm parameters and seminal 90K was observed between the two subgroups. 13 patients (26%) had identifiable bacteriospermia: significantly less pre-treatment seminal 90K was observed compared to patients without bacteriospermia. Conclusions: Seminal 90K is decreased in patients with male accessory gland infection, and may be restored by a treatment with quinolones. However, the clinical utility of a 90K assay in these patients remains uncertain as its level is not predictive of response to treatment.


Key words: Fertility • Prostate • Autoimmunity • Quinolones






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by The American Society of Andrology.